Affinity DataIC50: 9nMAssay Description:Irreversible inhibition of human recombinant MAGL using 4-nitrophenylacetate as substrate preincubated for 60 mins followed by substrate additionMore data for this Ligand-Target Pair
Affinity DataIC50: 26nMAssay Description:Irreversible inhibition of human recombinant MAGL using 4-nitrophenylacetate as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
Affinity DataIC50: 144nMAssay Description:Inhibition of human recombinant MAGL using 4-nitrophenylacetate as substrate after 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 146nMAssay Description:Irreversible inhibition of human recombinant MAGL using 4-nitrophenylacetate as substrateMore data for this Ligand-Target Pair
Affinity DataIC50: 8.60E+3nMAssay Description:Competitive inhibition of human recombinant MAGL using 4-nitrophenylacetate as substrate by Michaelis-Menten equation analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 1.17E+4nMAssay Description:Inhibition of human recombinant MAGL using 4-nitrophenylacetate as substrate after 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+4nMAssay Description:Irreversible inhibition of human recombinant MAGL using 4-nitrophenylacetate as substrateMore data for this Ligand-Target Pair
Affinity DataIC50: 1.22E+4nMAssay Description:Irreversible inhibition of human recombinant MAGL using 4-nitrophenylacetate as substrate preincubated for 60 mins followed by substrate additionMore data for this Ligand-Target Pair
Affinity DataIC50: 1.27E+4nMAssay Description:Irreversible inhibition of human recombinant MAGL using 4-nitrophenylacetate as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
Affinity DataIC50: 2.43E+4nMAssay Description:Inhibition of human recombinant MAGL using 4-nitrophenylacetate as substrate after 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: >5.00E+5nMAssay Description:Inhibition of human recombinant MAGL using 4-nitrophenylacetate as substrate after 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: >5.00E+5nMAssay Description:Inhibition of human recombinant MAGL using 4-nitrophenylacetate as substrate after 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: >5.00E+5nMAssay Description:Inhibition of human recombinant MAGL using 4-nitrophenylacetate as substrate after 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: >5.00E+5nMAssay Description:Inhibition of human recombinant MAGL using 4-nitrophenylacetate as substrate after 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: >5.00E+5nMAssay Description:Inhibition of human recombinant MAGL using 4-nitrophenylacetate as substrate after 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: >5.00E+5nMAssay Description:Inhibition of human recombinant MAGL using 4-nitrophenylacetate as substrate after 30 minsMore data for this Ligand-Target Pair
Affinity DataIC50: >5.00E+5nMAssay Description:Inhibition of human recombinant MAGL using 4-nitrophenylacetate as substrate after 30 minsMore data for this Ligand-Target Pair